SEC Form 4 research
| Issuer | Neumora Therapeutics, Inc. |
|---|---|
| Tickers | NMRA |
| Reporting owners | 32 |
| Officers and directors | 8 |
| Last public filing | 2026-08-22 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-21 | 2026-08-21 | Aurora Daljit Singh | S | 21,055 | $1.6 | Not reported |
| 2026-08-21 | 2026-08-21 | Aurora Daljit Singh | S | 20,553 | $1.59 | Not reported |
| 2026-08-21 | 2026-08-20 | Aurora Daljit Singh | S | 66,711 | $1.51 | Not reported |
| 2026-08-21 | 2026-08-20 | Aurora Daljit Singh | S | 67,741 | $1.51 | Not reported |
| 2026-08-21 | 2026-08-20 | Aurora Daljit Singh | A | 200,000 | $0 | Not reported |
| 2026-08-21 | 2026-08-20 | BERNS PAUL L | A | 500,000 | $0 | Not reported |
| 2026-08-21 | 2026-08-20 | Duncan Jason | A | 375,000 | $0 | Not reported |
| 2026-08-21 | 2026-08-20 | Milligan Michael Lee | A | 175,000 | $0 | Not reported |
| 2026-08-21 | 2026-08-20 | Pinto Joshua | A | 500,000 | $0 | Not reported |
| 2026-08-19 | 2026-08-19 | Aurora Daljit Singh | S | 30,918 | $1.65 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.